These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 19204708)

  • 1. Long-term outcomes following myeloablative allogeneic transplantation for multiple myeloma compared to autologous transplantation and the impact of graft-versus-myeloma effect.
    Khaled Y; Mellacheruvu S; Reddy P; Peres E; Mineishi S
    Bone Marrow Transplant; 2009 Sep; 44(5):325-6. PubMed ID: 19204708
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and molecular remission following reduced intensity conditioning and allogeneic transplantation in a patient with refractory multiple myeloma.
    Dodero A; Perfetti V; Ciceri F; Corradini P
    Haematologica; 2002 Dec; 87(12):ECR41. PubMed ID: 12495912
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of autologous and allogeneic hematopoietic cell transplant therapy for multiple myeloma.
    Arora M; McGlave PB; Burns LJ; Miller JS; Barke JN; Defor TE; Weisdorf DJ
    Bone Marrow Transplant; 2005 Jun; 35(12):1133-40. PubMed ID: 15834435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft-versus-myeloma after withdrawal of immunosuppression following allogeneic peripheral stem cell transplantation.
    Libura J; Hoffmann T; Passweg J; Gregor M; Favre G; Tichelli A; Gratwohl A
    Bone Marrow Transplant; 1999 Oct; 24(8):925-7. PubMed ID: 10516707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of stem cell transplantation.
    Harousseau JL
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1157-74, x. PubMed ID: 17996593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of allogeneic stem cell transplantation in multiple myeloma.
    Thomson KJ; Peggs KS
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):455-64. PubMed ID: 16001953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic haematopoietic cell transplantation for multiple myeloma: reducing transplant-related mortality while harnessing the graft-versus-myeloma effect.
    Zeiser R; Finke J
    Eur J Cancer; 2006 Jul; 42(11):1601-11. PubMed ID: 16759847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of allogeneic stem cell transplantation in multiple myeloma.
    Bruno B; Giaccone L; Sorasio R; Boccadoro M
    Semin Hematol; 2009 Apr; 46(2):158-65. PubMed ID: 19389499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Con: allogeneic transplantation in multiple myeloma.
    van Rhee F
    Clin Adv Hematol Oncol; 2006 May; 4(5):391-4. PubMed ID: 16728948
    [No Abstract]   [Full Text] [Related]  

  • 10. Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.
    Vesole DH; Simic A; Lazarus HM
    Bone Marrow Transplant; 2001 Oct; 28(8):725-35. PubMed ID: 11781623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants.
    Gahrton G; Iacobelli S; Apperley J; Bandini G; Björkstrand B; Bladé J; Boiron JM; Cavo M; Cornelissen J; Corradini P; Kröger N; Ljungman P; Michallet M; Russell NH; Samson D; Schattenberg A; Sirohi B; Verdonck LF; Volin L; Zander A; Niederwieser D
    Bone Marrow Transplant; 2005 Mar; 35(6):609-17. PubMed ID: 15696179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation.
    Galimberti S; Benedetti E; Morabito F; Papineschi F; Callea V; Fazzi R; Stelitano C; Andreazzoli F; Guerrini F; Ciabatti E; Martino M; Nobile F; Iacopino P; Petrini M
    Leuk Res; 2005 Aug; 29(8):961-6. PubMed ID: 15978948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation in multiple myeloma.
    Pant S; Copelan EA
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):877-85. PubMed ID: 17640590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving indications for hematopoietic stem cell transplantation in multiple myeloma and other plasma cell disorders.
    Tricot G; Zangari M; Sorasio R; Bruno B
    Cancer Treat Res; 2009; 144():317-55. PubMed ID: 19779883
    [No Abstract]   [Full Text] [Related]  

  • 15. The allogeneic dilemma.
    Harousseau JL
    Bone Marrow Transplant; 2007 Dec; 40(12):1123-8. PubMed ID: 17680016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma.
    Neelapu SS; Munshi NC; Jagannath S; Watson TM; Pennington R; Reynolds C; Barlogie B; Kwak LW
    Bone Marrow Transplant; 2005 Aug; 36(4):315-23. PubMed ID: 15968284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro: allogeneic transplantation in multiple myeloma.
    Gahrton G
    Clin Adv Hematol Oncol; 2006 May; 4(5):388-91. PubMed ID: 16728947
    [No Abstract]   [Full Text] [Related]  

  • 18. [Allogeneic stem cell transplantation with non-myeloablative or reduced-intensity conditioning for multiple myeloma].
    Nakaseko T; Nishimura M
    Rinsho Ketsueki; 2002 May; 43(5):341-4. PubMed ID: 12096482
    [No Abstract]   [Full Text] [Related]  

  • 19. [Multiple myeloma relapsed or progressed as plasmacytoma after allogeneic reduced-intensity stem cell transplantation: report of three cases].
    Sugimoto Y; Nishii K; Miyata E; Fujieda A; Yamaguchi M; Masuya M; Katayama N
    Rinsho Ketsueki; 2009 Apr; 50(4):289-94. PubMed ID: 19404022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-2-microglobulin level predicts outcome following autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
    Stella-Holowiecka B; Czerw T; Holowiecka-Goral A; Giebel S; Wojnar J; Holowiecki J
    Transplant Proc; 2007 Nov; 39(9):2893-7. PubMed ID: 18022010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.